Neddylation Modification Explored as Potential Target for Hepatocellular Carcinoma Treatment

Hepatocellular carcinoma (HCC), a prevalent form of liver cancer, presents ongoing challenges due to its high mortality rate and limited treatment options. Recent studies have focused on neddylation modification as a potential therapeutic target, due to its role in cancer progression. Neddylation modification is a key cellular process that influences the progression of cancer. Scientists are exploring this mechanism to develop targeted therapies. These therapies could potentially change the treatment of HCC in the future.

Newsflash | Powered by GeneOnline AI
Date: April 28, 2025

Related posts:

GLP-1 Weight Loss Drugs Might Cause Blindness Duke University Engineers Develop AI Platform to Target “Undruggable” Diseases Study Reveals Brain’s Role in Regulating Ear Sensitivity and Compensating for Hearing Loss February Roundup: Key Executive Changes in the Healthcare Sector

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後